Table 2 General characteristics of bid-winning antihypertensive drugs
Generic name | Dosage form | Specifications | Bid-winning enterprises | Time to market | Bid-winning prices (CNY per pill) | Prices before the policy (CNY per pill) | Price drop (%) |
|---|---|---|---|---|---|---|---|
Irbesartan | tablet | 75 mg | Zhejiang Huahai Pharmaceutical Co., Ltd. | Dec. 2017 | 0.20 | 0.66 | -69.41 |
Amlodipine | tablet | 5 mg | Zhejiang Jingxin Pharmaceutical Co.,Ltd. | Nov. 2018 | 0.15 | - | - |
Fosinopril | tablet | 10 mg | Sino-American Shanghai Squibb Pharmaceuticals Ltd.* | Dec. 2017 | 0.84 | 2.79 | -69.82 |
Irbesartan hydrochlorothiazide | tablet | 150 mg + 12.5 mg | Zhejiang Huahai Pharmaceutical Co., Ltd. | Dec. 2017 | 1.09 | 3.72 | -70.71 |
Lisinopril | tablet | 10 mg | Zhejiang Huahai Pharmaceutical Co., Ltd. | Dec. 2017 | 0.23 | 1.33 | -82.66 |
Losartan | tablet | 50 mg | Zhejiang Huahai Pharmaceutical Co., Ltd. | Dec. 2017 | 1.05 | 2.64 | -60.27 |
Enalapril | tablet | 5 mg | Yangtze River Pharmaceutical Group Co.,Ltd. | Apr. 2018 | 0.56 | 1.88 | -70.33 |